Clearline Capital LP - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 198 filers reported holding HERON THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 2.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
Clearline Capital LP ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,334,338
+104.8%
6,149,842
+130.7%
0.54%
+203.9%
Q2 2023$3,092,542
-2.0%
2,665,984
+27.6%
0.18%
-62.4%
Q1 2023$3,154,831
+23.1%
2,089,292
+103.9%
0.48%
+3.9%
Q4 2022$2,561,956
+357.5%
1,024,782
+2049.9%
0.46%
+76.8%
Q1 2020$560,000
+77.8%
47,667
+181.7%
0.26%
+68.2%
Q2 2019$315,000
-67.2%
16,920
-57.0%
0.15%
-69.3%
Q1 2019$961,000
-5.8%
39,3360.0%0.50%
-28.3%
Q4 2018$1,020,000
+4.7%
39,336
+27.9%
0.70%
+21.3%
Q3 2018$974,00030,7590.58%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders